1. Home
  2. PRU vs RVMD Comparison

PRU vs RVMD Comparison

Compare PRU & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prudential Financial Inc.

PRU

Prudential Financial Inc.

HOLD

Current Price

$114.84

Market Cap

42.4B

Sector

Finance

ML Signal

HOLD

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$200.59

Market Cap

42.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRU
RVMD
Founded
1875
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.4B
42.8B
IPO Year
2001
2020

Fundamental Metrics

Financial Performance
Metric
PRU
RVMD
Price
$114.84
$200.59
Analyst Decision
Hold
Strong Buy
Analyst Count
15
19
Target Price
$103.71
★ $140.84
AVG Volume (30 Days)
1.4M
★ 1.7M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
★ 5.81%
N/A
EPS Growth
★ 33.20
N/A
EPS
★ 4.48
N/A
Revenue
★ $60,774,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.06
$533.02
P/E Ratio
$25.91
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$91.89
$45.61
52 Week High
$127.72
$224.31

Technical Indicators

Market Signals
Indicator
PRU
RVMD
Relative Strength Index (RSI) 37.86 49.62
Support Level $111.58 $198.91
Resistance Level $124.07 $222.33
Average True Range (ATR) 2.16 7.48
MACD -0.29 -0.12
Stochastic Oscillator 5.04 53.79

Price Performance

Historical Comparison
PRU
RVMD

About PRU Prudential Financial Inc.

Prudential Financial is one of the largest US life insurers, offering annuities, life insurance, and asset-management products. The United States and Japan are its two largest markets. Its US business contributed about 50% of adjusted 2025 earnings and includes institutional retirement (mostly pension risk transfer), individual retirement (annuities), group insurance, and individual life insurance. Its international business represented about 39% of adjusted earnings, with a strong market position in Japan, and the firm also has a presence in emerging markets like Brazil. The company's investment management business, PGIM, contributed approximately 11% of its 2025 adjusted earnings. PGIM had around $1.47 trillion in assets under management at the end of fourth-quarter 2025.

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Share on Social Networks: